transgender hormone therapy also called hormone replacement therapy hrt genderaffirming hormone therapy gaht form hormone therapy sex hormones hormonal medications administered transgender gender nonconforming individuals purpose closely aligning secondary sexual characteristics gender identity form hormone therapy given one two types based whether goal treatment masculinization feminization eligibility transgender hormone therapy may concluded assessing patient gender dysphoria persistent gender incongruence though many medical institutions used informed consent model model ensures patients informed procedure process including possible benefits risks removing many historical barriers needed start hormone therapy treatment guidelines therapy developed several medical associations intersex people may also undergo hormone therapy either starting childhood confirm sex assigned birth later order align sex gender identity nonbinary people may also engage hormone therapy order achieve desired balance sex hormones help align bodies gender many transgender people obtain hormone therapy licensed health care provider others obtain selfadminister hormones formal requirements begin genderaffirming hormone therapy vary widely depending geographic location specific institution gender affirming hormones prescribed wide range medical providers including limited primary care physicians endocrinologists historically many health centers required psychiatric evaluation andor letter therapist beginning therapy many centers use informed consent model require routine formal psychiatric evaluation instead focuses reducing barriers care ensuring person understand risks benefits alternatives unknowns limitations risks lgbt health organizations notably chicagos howard brown health planned advocate type informed consent model standards care health transsexual transgender gender nonconforming people soc require patients seeking genderaffirmation hormone therapy evaluated gender dysphoria either mental health professional hormone provider qualified area transgender care standards also require patient give informed consent words consent treatment fully informed risks beginning genderaffirming hormone therapy patient must evaluated significant medical mental health concerns present must addressed reasonably world professional association transgender health wpath standards care edition note approaches care many international guidelines institutions require persistent welldocumented gender dysphoria prerequisite starting genderaffirmation therapy gender dysphoria refers psychological discomfort distress individual experience sex assigned birth incongruent persons gender signs gender dysphoria include comorbid mental health stressors depression anxiety low selfesteem social gender nonconforming individuals experience gender world professional association transgender health wpath endocrine society formulated guidelines created foundation health care providers care transgender ucsf guidelines also generally agreedupon set guidelines adolescents experiencing gender dysphoria may opt undergo pubertysuppressing hormone therapy onset puberty standards care set forth wpath recommend individuals pursuing pubertysuppressing hormone therapy wait least experiencing tanner stage pubertal tanner stage defined appearance scant pubic hair breast bud development andor slight testicular wpath classifies pubertysuppressing hormone therapy fully reversible intervention delaying puberty allows individuals time explore gender identity deciding permanent interventions prevents physical changes associated preferred pubertysuppressing agent individuals assigned male birth individuals assigned female birth gnrh approach temporarily shuts hypothalamicpituitarygonadal hpg axis responsible production hormones estrogen testosterone cause development secondary sexual characteristics feminizing hormone therapy typically used transgender women desire development feminine secondary sex characteristics individuals identify nonbinary may also optin feminizing hormone treatment better align body desired gender feminizing hormone therapy usually includes medication suppress testosterone production induce feminization types medications include estrogens antiandrogens testosterone blockers commonly estrogen combined antiandrogen suppress block allows demasculinization promotion feminization breast development estrogens administered various modalities including injection transdermal patch oral desired effects feminizing hormone therapy focus development feminine secondary sex characteristics desired effects include breast tissue development redistribution body fat decreased body hair reduction muscle mass table summarizes effects feminizing hormone therapy transgender women masculinizing hormone therapy typically used transgender men desire development masculine secondary sex characteristics masculinizing hormone therapy usually includes testosterone produce masculinization suppress production treatment options include oral parenteral subcutaneous implant transdermal patches gels dosing patientspecific discussed commonly prescribed methods intramuscular subcutaneous injections dosing weekly biweekly depending individual patientcitation needed unlike feminizing hormone therapy individuals undergoing masculinizing hormone therapy usually require additional hormone suppression estrogen suppression therapeutic doses testosterone usually sufficient inhibit production estrogen desired physiologic desired effects masculinizing hormone therapy focus development masculine secondary sex characteristics desired effects include increased muscle mass development facial hair voice deepening increase thickening body hair hormone therapy transgender individuals shown medical literature generally safe supervised qualified medical potential risks hormone treatment monitored screenings lab tests blood count hemoglobin kidney liver function blood sugar potassium taking medication directed may lead health problems increased risk cancer heart attack thickening blood blood clots elevated standards care published world professional association transgender health wpath summarize many risks associated feminizing hormone therapy outlined indepth information safety profile estrogenbased feminizing hormone therapy visit feminizing hormone therapy page standards care published world professional association transgender health wpath summarize many risks associated masculinizing hormone therapy outlined indepth information safety profile testosteronebased masculinizing hormone therapy visit masculinizing hormone therapy page transgender hormone therapy may limit fertility transgender individual choose undergo sex reassignment surgery fertility potential lost starting treatment individuals may consider fertility issues fertility preservation options include semen cryopreservation oocyte cryopreservation ovarian tissue study presented endo endocrine societys conference shows even one year treatment testosterone transgender man preserve fertility many providers use informed consent whereby someone seeking hormone therapy sign statement informed consent begin treatment without much gatekeeping providers eligibility determined using major diagnostic tools diagnostic statistical manual mental disorders dsm classify patient gender dysphoria psychiatric conditions commonly accompany present similar gender incongruence gender dysphoria reason patients assessed using criteria criteria addition screening psychiatric disorders endocrine society requires physicians diagnose gender dysphoria gender incongruence trained psychiatric disorders competency healthcare provider also obtain thorough assessment patients mental health identify potential psychosocial factors affect wpath standards care recently published outlines series guidelines met patient allowed transgender hormone replacement organizations fewer past require patients spend certain period time living desired gender role starting hormone therapy period sometimes called reallife experience rle endocrine society stated individuals either documented three months rle undergo psychotherapy period time specified mental health provider usually minimum three transgender gender nonconforming activists kate bornstein asserted rle psychologically harmful form gatekeeping effectively barring individuals transitioning long possible genderaffirming care health care affirms people live authentically genders matter gender assigned birth path gender affirmation transition takes allows person seek changes medical interventions desire affirm gender identity hormone therapy hrt genderaffirming hormone therapy may part transgender people choose selfadminister hormone replacement medications often doctors little experience area doctor available others selfadminister doctor prescribe hormones without letter psychotherapist stating patient meets diagnostic criteria making informed decision transition many therapists require least three months continuous psychotherapy andor reallife experience write letter many individuals must pay evaluation care outofpocket costs prohibitivecitation needed access medication poor even health care provided free patient survey conducted united kingdoms national health service respondents acknowledged resorting selfmedication dissatisfied amount time took receive hormone therapy report concluded part nhs must provide service easy access vulnerable patients feel forced turn diy remedies buying drugs online risks entails patients must able access professional help advice make informed decisions care whether wish take nhs private route without putting health indeed lives selfadministration hormone replacement medications without medical supervision may untoward health effects number private companies attempted increase accessibility hormone replacement medications help transgender people navigate complexities access treatmentcitation needed httpsenwikipediaorgwikitransgenderhormonetherapy